mesoestetic Pharma Group
Petar Balachev has a diverse work experience spanning over several industries. Petar currently holds the position of CRM Director at mesoestetic Pharma Group since May 2022. Prior to that, they worked as a Senior Manager at Deloitte Digital from September 2019 to January 2022. From March 2010 to September 2019, they served as the Head of CRM/Director de CRM at DDB. In addition, Petar has also worked as an Adjunct Professor in Marketing Research at ESCI-UPF International Business from December 2013 to April 2014, and as an Adjunct Professor in Business Economics at Pompeu Fabra University from January 2001 to April 2013. Petar has also held positions at Marketingcom as the Head of Management and IS Consulting from April 2009 to February 2010, and as a Senior Management Consultant from December 2007 to March 2009. Previously, Petar worked as a Research and Business Development Manager at Rosenthal Research from July 2006 to November 2007.
Petar Balachev's education history is as follows:
From 1989 to 1994, Petar attended First English Language School in Sofia, where they completed their high school education.
From 1995 to 1999, they attended Universitet za nacionalno i svetovno stopanstvo, where they obtained a Bachelor of Arts (BA) degree in European Business Administration.
During the same period, they also attended the University of Lincoln, where they earned a Bachelor of Arts (BA) degree in European Business Administration.
From 2000 to 2001, Petar pursued further studies at Universitat Pompeu Fabra, obtaining an MSc (Honours) degree in Management.
Finally, from 2001 to 2003, they continued studying at Universitat Pompeu Fabra and earned a Master of Advanced Studies degree in Management.
It should be noted that Petar Balachev's field of study for their high school degree is not provided.
This person is not in any offices
mesoestetic Pharma Group
mesoestetic Pharma Group is a pharmaceutical laboratory internationally recognized as one of the leaders in the field of dermatology and aesthetic medicine offering innovative and efficient solutions for skin treatment and care. The company manufactures cosmeceutical, nutraceuticals, class III intradermal administration medical devices with CE conformity marking, topical drugs as well as energy based medical aesthetic devices. This full range of integral aesthetic solutions is characterized by a high degree of innovation and significant scientific contribution. Since its inception in 1984, the firm has been committed to meeting strict pharmaceutical standards and complying with the most stringent European regulations. The company facilities are authorized by the Spanish Agency for Medicines and Medical Devices (AEMYPS) and include three pharmaceutical manufacturing lines (cosmeceuticals and nutraceuticals / intradermal administration medical devices / injectable and topical drugs), as well as a Biotechnology Unit and a Monitoring and Follow-Up Unit. These units enable the company to cover the entire production cycle and carry out in vitro and in vivo studies to ensure the safety and efficacy of its products.